Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,661–2,680 of 18,047 drug recalls

Drug Recall Ongoing Historical recordClass II

Artificial Tears Ointment, Sterile, For Ophthalmic Use Only, 3.5 gram tubes, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs

by Akorn, Inc.

Reason
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Recall initiated
April 26, 2023
Reported by FDA
June 7, 2023
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Artificial Tears Solution, Polyvinyl Alcohol 1.4%, For Ophthalmic Use Only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs

by Akorn, Inc.

Reason
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Recall initiated
April 26, 2023
Reported by FDA
June 7, 2023
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Apraclonidine Ophthalmic Solution 0.5%, packaged in a) 5mL and b) 10 mL bottles, Rx only, Sterile, For Topical Ophthalmic Use Only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs

by Akorn, Inc.

Reason
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Recall initiated
April 26, 2023
Reported by FDA
June 7, 2023
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL, packaged in a) 473mL bottles and b) 40 UD cups, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs

by Akorn, Inc.

Reason
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Recall initiated
April 26, 2023
Reported by FDA
June 7, 2023
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, packaged in a) 2 mL bottles b) 5 mL bottles, and C) 15 mL bottles, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs

by Akorn, Inc.

Reason
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Recall initiated
April 26, 2023
Reported by FDA
June 7, 2023
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Ongoing Historical recordClass II

Safe tussin PM, NIGHT TIME Cough Relief, (Dextromethorphan HBr, USP 7.5mg, Doxylamine Succinate 3.125mg), 4.0 FL OZ (118mL) bottle, Kramer Laboratories , Inc. Bridgewater, NJ 08807.

by Denison Pharmaceuticals, LLC

Reason
CGMP Deviations: Use of non-food grade lubricant in mixing vessel.
Recall initiated
May 3, 2023
Reported by FDA
June 7, 2023
Distribution
Product was distributed Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Pin-Away PYRENTAL PAMOATE (Pyrantel base 50 mg / mL) Pinworm Treatment, 2 FL OZ (60 mL) bottle, Distributed by: Cara Incorporated, 333 Strawberry Field Road, Warwick, RI 05886. NDC 70309-080-02

by Denison Pharmaceuticals, LLC

Reason
CGMP Deviations: Use of non-food grade lubricant in mixing vessel.
Recall initiated
May 3, 2023
Reported by FDA
June 7, 2023
Distribution
Product was distributed Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.

by Revive Rx LLC dba Revive Rx Pharmacy

Reason
Sub-potent Drug
Recall initiated
May 11, 2023
Reported by FDA
May 31, 2023
Distribution
Nationwide in the US

View recall →

Drug Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28

by Teva Pharmaceuticals USA Inc

Reason
Labeling: Incorrect or Missing Package Insert
Recall initiated
April 27, 2023
Reported by FDA
May 31, 2023
Distribution
US Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-637-28

by Teva Pharmaceuticals USA Inc

Reason
Labeling: Incorrect or Missing Package Insert
Recall initiated
April 27, 2023
Reported by FDA
May 31, 2023
Distribution
US Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 400mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-636-28

by Teva Pharmaceuticals USA Inc

Reason
Labeling: Incorrect or Missing Package Insert
Recall initiated
April 27, 2023
Reported by FDA
May 31, 2023
Distribution
US Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-635-28

by Teva Pharmaceuticals USA Inc

Reason
Labeling: Incorrect or Missing Package Insert
Recall initiated
April 27, 2023
Reported by FDA
May 31, 2023
Distribution
US Nationwide

View recall →

Drug Recall Terminated Historical recordClass III

Fentanyl Buccal Tablets CII, 100mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-634-28

by Teva Pharmaceuticals USA Inc

Reason
Labeling: Incorrect or Missing Package Insert
Recall initiated
April 27, 2023
Reported by FDA
May 31, 2023
Distribution
US Nationwide

View recall →

Drug Recall Completed Historical recordClass II

Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; NDC 0363-9947-35.

by Aurobindo Pharma USA Inc.

Reason
Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
Recall initiated
May 22, 2023
Reported by FDA
May 31, 2023
Distribution
The recalled product was distributed to one Retail Distributor (Walgreens) who further distributed Nationwide in the USA.

View recall →

Drug Recall Ongoing Historical recordClass II

Nafcillin for Injection, USP, 10 gram per Pharmacy Bulk Package, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-141-99

by Sagent Pharmaceuticals Inc

Reason
Lack of Assurance of Sterility
Recall initiated
May 19, 2023
Reported by FDA
May 31, 2023
Distribution
Nationwide USA

View recall →

Drug Recall Ongoing Historical recordClass II

Nafcillin for Injection, USP, 2 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-140-10

by Sagent Pharmaceuticals Inc

Reason
Lack of Assurance of Sterility
Recall initiated
May 19, 2023
Reported by FDA
May 31, 2023
Distribution
Nationwide USA

View recall →

Drug Recall Ongoing Historical recordClass II

Nafcillin for Injection, USP, 1 gram per vial, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195. NDC: 25021-139-10

by Sagent Pharmaceuticals Inc

Reason
Lack of Assurance of Sterility
Recall initiated
May 19, 2023
Reported by FDA
May 31, 2023
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Failed Dissolution Specifications; during stability testing
Recall initiated
May 9, 2023
Reported by FDA
May 31, 2023
Distribution
Nationwide in the U.S.A

View recall →

Drug Recall Terminated Historical recordClass II

FOAMING HAND SANITIZER, fresh mint scent, 62% alcohol, 1 Gallon / 3.78 Liters bottle, 290 Alpha Drive RIDC industrial Park, Pittsburgh, PA 15238,

by Alpha Aromatics

Reason
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
Recall initiated
May 16, 2023
Reported by FDA
May 31, 2023
Distribution
Product was distributed to one account in NC.

View recall →

Drug Recall Terminated Historical recordClass II

Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA. For BluePoint Laboratories

by Amerisource Health Services LLC

Reason
CGMP Deviations: recalling drug products following an FDA inspection.
Recall initiated
March 17, 2023
Reported by FDA
May 31, 2023
Distribution
Nationwide USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.